X5M-24276-76584
2 vaccinations
3 coded responses
26 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 982 / WA
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-01
Registered in v-safe
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Heart rate increased, Palpitations — Feeling: Good · Site: PainFree text: Yesterday forgot to report racing heartbeatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-08
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-06-29
- 2021-09-28
-
2021-10-27
Dose 2 — Moderna
-
2021-10-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-29
Survey response — days 1–6 daily, dose 2MedDRA: Pregnancy test positive — Feeling: Good · Site: PainFree text: Positive pregnancy testMedDRA releases: 2024-11 · check-in free text available
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-17
- 2021-11-25
- 2021-12-01
- 2021-12-08
- 2022-01-26
-
2022-04-27
Survey response — 6 months, dose 2MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Gestational diabetesMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-27 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-27 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Yesterday forgot to report racing heartbeat
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Positive pregnancy test
Release 11 — 6 months, dose 2
Symptoms: Gestational diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational diabetes | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Palpitations | ✓ | ✓ | ○ |
| SRO | Pregnancy test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release